Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Jump to section
Related Articles
Cited By...
- Intravenous cangrelor and oral ticagrelor as an alternative to clopidogrel in acute intervention
- Effect of bodyweight on VerifyNow Aspirin platelet function test: a retrospective review
- Efficacy of a two-test protocol for achieving a therapeutic response to clopidogrel prior to elective endovascular intracranial aneurysm treatment and an 'induced postoperative hyper-response
- Diabetes mellitus and carotid artery plaques exhibiting high-intensity signals on MR angiography are related to increased platelet reactivity after carotid artery stenting
- Flow diverter device for the treatment of small middle cerebral artery aneurysms
- Association between CYP2C19 Polymorphisms and Outcomes in Cerebral Endovascular Therapy
- Clopidogrel Resistance in Neurovascular Stenting: Correlations between Light Transmission Aggregometry, VerifyNow, and the Multiplate
- Comparing prasugrel to twice daily clopidogrel post percutaneous coronary intervention in a Veterans Affairs population
- Tailoring platelet inhibition according to multiple electrode aggregometry decreases the rate of thrombotic complications after intracranial flow-diverting stent implantation
- Variability in initial response to standard clopidogrel therapy, delayed conversion to clopidogrel hyper-response, and associated thromboembolic and hemorrhagic complications in patients undergoing endovascular treatment of unruptured cerebral aneurysms
- Platelet function inhibitors and platelet function testing in neurointerventional procedures
- Carotid artery stenting outcomes: do they correlate with antiplatelet response assays?
- Incidence of Microemboli and Correlation with Platelet Inhibition in Aneurysmal Flow Diversion
- Prevention of stent thrombosis with reduced dose of prasugrel in two patients undergoing treatment of cerebral aneurysms with pipeline embolisation devices
- Clopidogrel Hyper-Response and Bleeding Risk in Neurointerventional Procedures
- Clopidogrel Resistance Is Associated with Thromboembolic Complications in Patients Undergoing Neurovascular Stenting
- Prevention of stent thrombosis with reduced dose of prasugrel in two patients undergoing treatment of cerebral aneurysms with pipeline embolisation devices
- Body weight: a risk factor for subtherapeutic antithrombotic therapy in neurovascular stenting
- Neuroform Stent-Assisted Coiling of Unruptured Intracranial Aneurysms: Short- and Midterm Results from a Single-Center Experience with 68 Patients
- Preinterventional Clopidogrel Response Variability for Coil Embolization of Intracranial Aneurysms: Clinical Implications
- Platelet Aggregation in Intracranial Stents May Mimic In-Stent Restenosis
- The learning curve for neuroendovascular procedures: How important is it?
- Advances in Interventional Neuroradiology
- Prevalence and Risk Factors for Aspirin and Clopidogrel Resistance in Patients with Coronary Artery Disease or Ischemic Cerebrovascular Disease